BioHarvest Sciences (BHST) Expected to Announce Earnings on Thursday

BioHarvest Sciences (NASDAQ:BHST) is expected to announce its Q1 2025 earnings results after the market closes on Thursday, May 15th. Analysts expect the company to announce earnings of ($0.15) per share and revenue of $7.80 million for the quarter.

BioHarvest Sciences (NASDAQ:BHST) last issued its quarterly earnings data on Monday, March 31st. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.05). The firm had revenue of $7.17 million for the quarter, compared to analysts’ expectations of $7.24 million. On average, analysts expect BioHarvest Sciences to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

BioHarvest Sciences Price Performance

BHST stock opened at $6.61 on Tuesday. The stock has a market cap of $108.57 million, a P/E ratio of -5.29 and a beta of 0.80. The company has a fifty day moving average price of $6.01. BioHarvest Sciences has a 12-month low of $6.45 and a 12-month high of $7.38.

Wall Street Analyst Weigh In

Several research analysts recently commented on the company. Craig Hallum assumed coverage on BioHarvest Sciences in a research note on Monday, May 5th. They set a “buy” rating and a $15.00 target price for the company. HC Wainwright reiterated a “buy” rating and set a $14.00 price target on shares of BioHarvest Sciences in a research note on Tuesday, April 8th.

BioHarvest Sciences Company Profile

BioHarvest Sciences Inc is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications.